Skip to main content
Springer logoLink to Springer
. 2012 Jan 28;143(4):657–667. doi: 10.1007/s00706-011-0715-z

Synthesis and RP HPLC studies of biologically active semicarbazides and their cyclic analogues 1,2,4-triazol-3-ones

Monika Pitucha 1,, Joanna Matysiak 2, Bogdan Senczyna 2
PMCID: PMC4495053  PMID: 26166864

Abstract

Abstract

The retention behaviour of semicarbazides and their cyclic analogues 1,2,4-triazol-3-ones, has been investigated by RP-8, RP-18 and IAM HPLC. The structures of new derivatives were proved by elemental analyses, IR, 1H NMR and 13C NMR spectroscopy. The compounds showed regular retention behaviour in three chromatographic systems; their log k values decreased linearly with the increasing concentration of an organic modifier in the mobile phase. The ratio of the intercept (log k w) to the slope of compounds is constant and the same for both groups of compounds on C18 and IAM stationary phases. Differences between log k w values from the octadecyl stationary phase of corresponding cyclic and linear derivatives are constant, and they are related to the mechanism of synthesis of 1,2,4-triazol-3-ones from linear substrate semicarbazides, which was confirmed by modelling studies. Good correlations between log k w parameters obtained by RP-8 or RP-18 and determined by the computational approach log P were found.

Graphical Abstract

graphic file with name 706_2011_715_Figa_HTML.jpg

Keywords: Semicarbazide; 1,2,4-Triazol-3-one; RP HPLC; IAM chromatography; Lipophilicity

Introduction

Triazoles and their heterocyclic derivatives represent an interesting class of compounds possessing a wide spectrum of biological activities [14], including antibacterial ones [5, 6]. Examples of drugs bearing the 1,2,4-triazole residue are the powerful azole antifungal agent fluconazole [7], as well as the potent antiviral N-nucleoside ribavirin [8].

Their linear analogues, semicarbazides, commonly applied in the 1,2,4-triazole synthesis, are also an important class of compounds of diverse biological properties. They have been studied as anticonvulsant [9], antitubercular [10] and antinociceptive [11] agents. Additionally, the derivatives having the heterocyclic ring exhibit antibacterial activity, inhibiting growth of some gram-positive bacteria, including B. cereus and M. luteus [12]. Some of them show antinociceptive activity in a wide range of doses [13].

It is commonly known that biological activity of compounds is a function of their lipophilicity. Reversed phase (RP) chromatographic methods have been extensively applied to determine this property of many bioactive compounds [14, 15]. The use of alkyl-bonded phases in liquid chromatography offers a convenient and highly accurate method for the evaluation of the lipophilicity of a large variety of compounds [16, 17]. As the HPLC stationary phase for the determination of phase affinity of compounds, the immobilized artificial membrane (IAM) is also used [1820].

A linear relationship between the retention parameters (log k) and the concentration (φ) of organic modifier (acetonitrile, methanol, or others) in the aqueous mobile phase described by the Soczewiński-Wachtmeister equation (Eq. 1) has to be established for a successful chromatographic measurement of lipophilicity [21, 22].

graphic file with name 706_2011_715_Article_Equ1.gif 1

log k w represents the retention factor of a solute with pure water as the mobile phase; S is the slope of the regression curve. This dependence allows for the extrapolation from the data obtained for the water-organic modifier to water as the mobile phase. On the basis of log k = f(φ) relationships, the lipophilicity parameter log k w and the specific hydrophobic surface area S can be calculated. Lipophilicity chromatographic descriptors obtained in this way help explain differences in the bioactivity of similar structure derivatives. They are usually used for QSAR model building, prediction of biological activity of new structure related analogues, and design and synthesis of more effective new derivatives [23, 24].

In this work comparable chromatographic studies of biologically active mono- and bis-1,2,4-triazol-3-ones as well as their linear analogues, semicarbazides, were carried out. The octyl, octadecyl and IAM stationary phases were used. To explain differences in the retention behaviour of compounds of both groups, molecular modeling was performed. Log P values obtained from the computational approach were used comparatively.

Results and discussion

The structures of compounds under consideration are presented in Scheme 1. They include linear semicarbazides (a) and their cyclic analogues 3H-1,2,4-triazol-3-ones (b). The compounds of structure b were obtained by condensation reaction of a in alkaline medium. The process of water molecule elimination from compounds 1a13a or two molecules from 14a and 15a gives the corresponding 3H-1,2,4-triazol-3-ones 1b15b.

Scheme 1.

Scheme 1

 

The substitution panel of compounds under consideration includes heterocyclic, aryl, alkyl and alkenyl groups. The structures of new derivatives were proved by elemental analyses, IR, 1H NMR and 13C NMR spectroscopy.

The UV-Vis spectra in water-methanol solutions of different pH of compounds 13a and 13b are presented in Fig. 1. They show that there are no significant changes in their electronic structure at pH 2–8. As pH 7.4 (physiological) is recommended for IAM chromatography measurements, for comparison all chromatographic experiments were performed at this pH.

Fig. 1.

Fig. 1

UV–Vis spectra of compounds 13a and 13b in methanol-water solution of different pH

The log k values of compounds were determined using C-8, C-18 and IAM stationary phases. The mobile phases consisted of buffer mixed with various amounts of methanol or acetonitrile to give pH 7.4. Linear relationships were obtained between the log k and φ in the mobile phase in the whole studied ranges for all stationary phases. Generally, for semicarbazide derivatives and IAM chromatography, a larger content of water in the mobile phase can be used (Tables 1, 2). For some compounds log k w values on IAM were determined experimentally. The chromatograms of compound 12a are shown in Fig. 2.

Table 1.

Chromatographic parameters: log k w (intercept) and −S (slope) of the linear dependences in Eq. 1 obtained by RP-8 and RP-18 chromatography

RP-8 HPLC RP-18 HPLC
S Intercept r 2 φ MeOH n S Intercept r 2 φ MeOH n
1a 3.978 1.946 0.970 0.70–0.25 7 1.880 0.783 0.982 0.75–0.35 7
2a 3.847 2.144 0.979 0.70–0.35 5 2.279 1.279 0.981 0.75–0.35 7
3a 3.449 1.022 0.984 0.70–0.20 6 1.155 0.089 0.984 0.75–0.35 7
4a 3.728 1.717 0.981 0.70–0.25 7 2.065 0.871 0.982 0.75–0.30 8
5a 2.967 0.797 0.991 0.55–0.10 9 0.910 −0.074 0.901 0.75–0.30 7
6a 3.371 1.563 0.992 0.70–0.20 7 1.959 0.864 0.992 0.75–0.30 7
7a 4.872 2.443 0.984 0.55–0.30 6 2.365 1.280 0.960 0.75–0.35 6
8a 2.919 0.799 0.991 0.70–0.10 9 0.987 0.014 0.984 0.75–0.30 7
9a 2.948 0.721 0.990 0.70–0.10 9 1.257 0.155 0.972 0.75–0.30 7
10a 2.293 0.581 0.990 0.70–0.10 9 0.854 −0.154 0.907 0.75–0.30 7
11a 3.725 1.783 0.977 0.70–0.30 6 1.452 0.479 0.934 0.75–0.30 7
12a 3.422 1.682 0.985 0.70–0.25 7 1.506 0.471 0.857 0.75–0.30 7
13a 3.386 1.234 0.992 0.70–0.10 9 1.451 0.446 0.988 0.75–0.35 6
14a 4.398 1.705 0.970 0.70–0.20 8 0.590 −0.352 0.949 0.75–0.30 7
15a 4.401 1.998 0.930 0.70–0.25 7 1.406 0.270 0.953 0.75–0.30 6
1b 4.140 2.350 0.972 0.70–0.35 5 2.392 1.341 0.963 0.75–0.40 6
2b 4.153 2.434 0.978 0.70–0.35 5 2.623 1.545 0.965 0.75–0.40 6
3b 3.301 1.324 0.973 0.70–0.20 7 1.353 0.335 0.973 0.75–0.35 7
4b 3.841 2.139 0.974 0.70–0.25 5 2.507 1.439 0.964 0.75–0.40 6
5b 3.539 1.550 0.981 0.55–0.20 7 1.591 0.540 0.931 0.75–0.30 7
6b 3.601 1.987 0.975 0.80–0.30 7 2.670 1.514 0.975 0.75–0.40 6
7b 5.124 2.893 0.959 0.70–0.40 6 3.268 2.069 0.965 0.75–0.40 6
8b 3.637 1.661 0.980 0.70–0.20 8 1.758 0.745 0.892 0.75–0.35 7
9b 3.417 1.551 0.979 0.70–0.20 8 1.757 0.758 0.995 0.75–0.30 7
10b 2.711 0.874 0.975 0.70–0.10 9 1.767 0.36 0.853 0.75–0.30 7
11b 4.591 2.172 0.981 0.70–0.30 6 1.905 0.862 0.985 0.75–0.30 7
12b 4.829 2.244 0.981 0.70–0.30 6 2.331 0.977 0.899 0.75–0.30 7
13b 3.793 1.923 0.973 0.70–0.30 6 2.211 1.126 0.925 0.75–0.30 6
14b 6.725 3.038 0.979 0.70–0.30 6 1.974 0.792 0.991 0.75–0.30 7
15b 6.305 3.311 0.954 0.70–0.35 5 2.821 1.531 0.902 0.75–0.30 7

Table 2.

Chromatographic parameters: log k w (intercept) and −S (slope) of the linear dependences in Eq. 1 obtained by IAM chromatography and log P values

IAM HPLC log P
S Intercept r 2 φ ACN n
1a 5.094 1.257 0.995 0.30–0.05 6 0.91
2a 5.358 1.847 0.993 0.30–0.10 5 1.53
3a 3.514 0.067 0.901 0.40–0.15 6 −0.63
4a 4.077 0.825 0.997 0.30–0.00 7 0.77
5a 2.458 0.097 0.955 0.25–0.00 6 −0.27
6a 4.626 1.230 0.995 0.50–0.15 8 1.90
7a 5.061 1.522 0.995 0.30–0.05 6 2.39
8a 2.453 0.003 0.868 0.30–0.00 7 0.58
9a 2.783 0.101 0.993 0.30–0.00 7 0.09
10a 2.581 0.206 0.965 0.30–0.00 7 −0.39
11a 5.227 1.137 0.997 0.30–0.05 6 0.47
12a 4.588 0.740 0.993 0.30–0.00 7 0.79
13a 3.318 0.318 0.986 0.30–0.00 6 0.95
14a 6.727 1.459 0.998 0.30–0.05 6 0.21
15a 7.091 1.725 0.996 0.30–0.05 6 1.52
1b 5.878 1.543 0.996 0.30–0.05 6 2.04
2b 5.519 1.705 0.996 0.30–0.10 5 2.65
3b 4.228 0.441 0.985 0.40–0.15 6 0.50
4b 5.211 1.391 0.998 0.30–0.05 6 1.90
5b 4.062 0.513 0.995 0.30–0.00 7 0.85
6b 4.761 1.243 0.998 0.50–0.15 8 3.03
7b 5.900 1.760 0.997 0.30–0.10 5 3.52
8b 4.274 0.712 0.995 0.30–0.00 7 1.70
9b 3.782 0.584 0.908 0.30–0.00 7 1.22
10b 3.994 0.158 0.998 0.30–0.00 7 0.74
11b 5.374 0.985 0.986 0.30–0.05 6 1.59
12b 5.924 1.056 0.994 0.30–0.00 7 1.92
13b 4.593 0.935 0.996 0.30–0.00 7 2.08
14b 6.902 1.322 0.994 0.30–0.05 6 2.47
15b 7.684 1.913 0.997 0.30–0.10 5 3.78

Fig. 2.

Fig. 2

Chromatograms of compound 12a obtained by IAM chromatography for different water contents in water/ACN mobile phase

The equations of the straight lines and statistics for three techniques are reported in Tables 1 and 2. As follows from the tables the absolute values of the slopes |S| are the highest for the IAM stationary phase for both semicarbazides and 3H-1,2,4-triazol-3-ones. In the case of RP-8 and RP-18 chromatography, the log k w values for the linear structures (1a15a) are lower than for the cyclic ones (1b15b).

Biagi et al. [25] found that for closely congeneric compounds, the ratio of the intercept (log k w) to the slope (S) in Eq. 1 is constant. The relationships between these parameters of semicarbazides (a) for RP-8, 18 and IAM chromatography are expressed by the following equations:

graphic file with name 706_2011_715_Article_Equ2.gif 2
graphic file with name 706_2011_715_Article_Equ3.gif 3
graphic file with name 706_2011_715_Article_Equ4.gif 4

In the case of their cyclic analogues 3H-1,2,4-triazol-3-ones (b), these relations are described by Eqs. 57:

graphic file with name 706_2011_715_Article_Equ5.gif 5
graphic file with name 706_2011_715_Article_Equ6.gif 6
graphic file with name 706_2011_715_Article_Equ7.gif 7

The best results were obtained for the C-18 stationary phase (Eqs. 3, 6). However, in all cases congenerity of compounds was confirmed. The slopes of Eqs. 2 and 5, 3 and 6, as well as 4 and 7 are similar. This may indicate the same retention mechanism of both studied compounds in these chromatographic systems. The relationships between the intercept (log k w) and the slope (–S) of both groups of compounds for three chromatographic systems are presented in Figs. 3, 4 and 5.

Fig. 3.

Fig. 3

Relationship between the intercept (log k w) and slopes (−S) of both groups of compounds (a and b) obtained by RP-8 stationary phase (Eq. 8)

Fig. 4.

Fig. 4

Relationship between the intercept (log k w) and slopes (−S) of both groups of compounds (a and b) obtained by RP-18 stationary phase (Eq. 9)

Fig. 5.

Fig. 5

Relationship between the intercept (log k w) and slopes (−S) of both groups of compounds (a and b) obtained by IAM stationary phase (Eq. 10)

They are expressed by the following equations:

graphic file with name 706_2011_715_Article_Equ8.gif 8
graphic file with name 706_2011_715_Article_Equ9.gif 9
graphic file with name 706_2011_715_Article_Equ10.gif 10

Compounds 2a and 2b are outliers in IAM chromatography. The equations show that semicarbazides and corresponding 3H-1,2,4-triazol-3-ones are a set of congeneric compounds [25, 26]. Therefore, they were analyzed together during further studies.

The relationships between the log k w values obtained by different chromatographic techniques are not very powerful. It can be assumed that compounds 14 and 15 (with two semicarbazide moieties or two triazole rings) are outliers. Under this assumption, the relationships between the intercepts (log k w) are described in the following way:

graphic file with name 706_2011_715_Article_Equ11.gif 11
graphic file with name 706_2011_715_Article_Equ12.gif 12
graphic file with name 706_2011_715_Article_Equ13.gif 13

The weakest correlation was found between the most hydrophobic phase and the most polar one (Eq. 12).

For comparison, the theoretical values of log P were calculated according to the fragmentation method introduced by Crippen [27]. The analysis of both groups of compounds gives the following equation:

graphic file with name 706_2011_715_Article_Equ14.gif 14
graphic file with name 706_2011_715_Article_Equ15.gif 15

Compounds 14 and 15 are outliers in Eq. 14. In the case of IAM chromatography very poor correlation was obtained (r = 0.753, n = 30).

Markedly different chromatographic behaviour of solutes on the IAM chromatography is a result of some differences in the stationary phase structure [28]. Generally, the correlation between the logarithms of the retention factor determined on the IAM columns log k w(IAM) and the reference parameter of hydrophobicity, log D as well as log k w(C18) (logP) is not large [29]. However, the log k w(IAM) values appeared to be a better predictor of bioactivity than log D for several classes of drugs [29, 30].

As the transformation of semicarbazides into 3H-1,2,4-triazol-3-ones is associated with the elimination of water, the differences between log k w(b) and log k w(a) values, Δ log k w, were calculated. Table 3 shows that the lipophilicity differences between the corresponding derivatives in RP-18 chromatography, Δ log k w(C18), are in the range about 0.5–0.7. Higher values (about 1.2) for compounds 14 and 15 were found. They are formed by the elimination of two water molecules from the linear substrates (Scheme 1), so the lipophilicity differences are about twice as large. A similar trend for RP-8 chromatography was observed (Table 3). This finding reflects the synthesis mechanism of compounds of structure b from a. At the same time it shows that the elimination of water from a molecule reduces its lipophilicity as well as absolute values of the specific hydrophobic surface, and the ratio of the intercept (log k w) to the slope (−S) of compounds is constant in both groups. The obtained results are in accordance with the fragmental method used for log P calculations [27]. The differences between log P values of compound structures b and a are equal 1.13 (1.12) for analogues 113 and 2.26 for 14 and 15. The differences between the log k w(IAM(b)) and log k w(IAM(a)) values, Δ log k w(IAM), are varied (Table 3).

Table 3.

The lipophilicity differences between the 3H-1,2,4-triazol-3-ones and the corresponding semicarbazides (Δ log k w) obtained by different chromatographic systems

Δ log k aw(8) Δ log k bw(C18) Δ log k cw(IAM)
1a,b 0.404 0.558 0.286
2a,b 0.290 0.266 −0.142
3a,b 0.301 0.246 0.373
4a,b 0.422 0.568 0.566
5a,b 0.754 0.614 0.415
6a,b 0.423 0.650 0.013
7a,b 0.450 0.789 0.238
8a,b 0.862 0.731 0.709
9a,b 0.830 0.603 0.483
10a,b 0.293 0.514 −0.048
11a,b 0.389 0.383 −0.152
12a,b 0.563 0.506 0.316
13a,b 0.689 0.680 0.617
14a,b 1.333 1.144 −0.138
15a,b 1.313 1.261 0.189

aΔ log k w(C8) = log k w(C8(b)) − log k w(C8(a))

bΔ log k w(C18) = log k w(C18(b)) − log k w(C18(a))

cΔ log k w(IAM) = log k w(IAM(b)) − log k w(IAM(a))

To compare the structures of compounds quantum mechanical calculations were carried out with the semi-empirical model at the PM3 basis set. In Fig. 6 compounds 7a and 7b are shown as representative analogues of the analysed groups.

Fig. 6.

Fig. 6

Optimised structures of 7a and 7b and the MEPs of the electrostatic potential profile at −84 kJ mol−1

As follows from Fig. 6 elimination of water from an a molecule remarkably changes its shape, flexibility and dipole moment, and decreases both the area and volume. Of course, changes of individual compounds are also a function of the substituents. The MEPs, the electrostatic potential profile of compounds, show that the most negative potential of compound structure a is located on four heteroatoms of the semicarbazide moiety (without taking the substituent into account). In the cyclic analogues b it covers mainly two oxygen atoms. The area and volume reduction of b compared to a is associated with reduction of the polar local area of molecules. It causes stronger interactions with the hydrophobic octadecyl or octyl stationary phases and increases lipophilicity.

In conclusion, new semicarbazides and corresponding 1,2,4-triazol-3-one derivatives have been synthesized. In RP-8, RP-18 and IAM chromatography, the dependences of log k versus the concentration of an organic modifier (φ) in the mobile phase were linear. The constant ratio of the intercept (log k w) to the slope (−S) of compounds showed that the compounds of both groups are congeneric according to Biagi. The differences in the retention behaviour of compounds of structures b and a in C-18 and C-8 chromatography reflect the synthesis method of 1,2,4-triazol-3-ones from linear substrates connected with the elimination of water from a molecule. The good correlation coefficient between the log k w values obtained by octadecyl and octyl phases suggests that these parameters can be used independently in the evaluation of compounds under consideration.

Experimental

Melting points were determined in a Fisher-Johns block. Elemental analyses (C, H, N) were conducted using an Elemental Analyser CHN; their results were found to be in good agreement with the calculated values. IR spectra were recorded from KBr discs using a Specord IR-75 spectrophotometer. 1H NMR spectra were recorded on a Bruker AC 300F instrument (300 MHz) in DMSO-d 6 with TMS as an internal standard. 13C NMR spectra were recorded on a Bruker AC 250F instrument (62.5 MHz) in DMSO-d 6 with TMS as an internal standard. Chemicals were purchased from Alfa-Aesar or Merck. The purity of the obtained compounds was checked by TLC on aluminum oxide 60 F254 plates (Merck) in a CHCl3/C2H5OH (10:1 and 10:2) solvent system with UV or iodine visualization. Compounds 14, 68, 11a13a and 14 were synthesized and characterized earlier [3135].

Synthesis of 1,4-disubstituted semicarbazides

To 10 mmol of appropriate carboxylic acid hydrazide dissolved in 10 cm3 of diethyl ether 10 mmol isocyanate was added. The mixture was kept at room temperature for 24 h. The precipitate was filtered and crystallized from ethanol.

1-Methyl-1H-pyrrole-2-acetic acid 2-[(2-propenylamino)carbonyl]hydrazide (5a, C11H16N4O2)

Yield 1.96 g (83%); m.p.: 137–139 °C; IR (KBr): Inline graphic = 3,279, 3,192, 3,034, 1,701, 1,649, 1,444 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.32 (s, 2H), 3.52 (s, 3H), 3.61–3.65 (m, 2H), 4.98–5.15 (m, 2H), 5.72–5.84 (m, 1H), 6.85–7.63 (m, 3H, pyrrole-H), 7.63 (s, NH), 7.78 (s, NH), 9.60 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 31.45 (CH2), 33.52 (CH3), 41.42 (CH2), 106.01 (CH), 107.84 (Carom), 114.40 (CH2), 121.82, 126.09, 136.28 (3 × Carom), 157.91 (C=O), 169.26 (C=O) ppm.

Pyridine-2-carboxylic acid 2-[(2-propenylamino)carbonyl]hydrazide (9a, C10H12N4O2)

Yield 1.76 g (80%); m.p.: 195–197 °C; IR (KBr): Inline graphic = 3,261, 3,013, 2,814, 1,697, 1,651, 1,487 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.63–3.72 (m, 2H), 4.98–5.18 (m, 2H), 5.71–5.86 (m, 1H), 6.59 (s, NH), 7.56–8.08 (m, 4H, pyridine-H), 8.72 (s, NH), 10.26 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 13.31 (CH2), 61.74 (CH2), 113.06 (CH), 123.12, 130.03, 143.23, 148.01, 152.48 (5 × Carom), 154.21 (C=O), 167.73 (C=O) ppm.

Pyridine-4-acetic acid 2-[(2-propenylamino)carbonyl]hydrazide (10a, C11H14N4O2)

Yield 1.62 g (69%); m.p.: 130–131 °C; IR (KBr): Inline graphic = 3,309, 3,267, 2,960, 1,644, 1,598, 1,455 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.49 (s, 2H), 3.56–3.70 (m, 2H), 5.00–5.15 (m, 2H), 5.72–5.85 (m, 1H), 6.53 (t, J = 5.6 Hz, NH), 7.20–8.49 (m, 4H, pyridine-H), 7.85 (s, NH), 9.82 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 40.00 (CH2), 40.11 (CH2), 113.12 (CH2), 123.26 (CH), 123.82, 143.26, 147.78, 147.96 (5 × Carom), 156.62 (C=O), 167.68 (C=O) ppm.

Propanoic acid 1,1′-[2,2′-[methylenebis(4,1-phenyleneiminocarbonyl)]dihydrazide] (15a, C21H26N6O4)

Yield 3.49 g (82%); m.p.: 356–358 °C; IR (KBr): Inline graphic = 3,304, 3,032, 2,977, 1,650, 1,463 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 1.95–2.07 (m, 6H), 2.10–2.35 (m, 4H), 3.80 (s, 2H), 7.06–7.39 (m, 8H, phenyl-H), 7.90 (s, 2NH), 8.64 (s, 2NH), 9.54 (s, 2NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 7.01 (2 × CH3), 8.26 (2 × CH2), 25.06 (CH2), 117.38, 118.72, 127.42, 133.80, 136.07 (12 × Carom), 154.20 (2 × C=O), 170.80 (2 × C=O) ppm.

Synthesis of 4,5-disubstituted 2,4-dihydro-3H-1,2,4-triazol-3-one derivatives

A mixture of 10 mmol of semicarbazide derivatives a and 50 cm3 of 2% aqueous solution of sodium hydroxide was refluxed for 20 h. After cooling, the solution was neutralized with dilute hydrochloric acid. The precipitate was filtered off and then crystallized from ethanol.

2,4-Dihydro-5-[(1-methyl-1H-pyrrol-2-yl)methyl]-4-(2-propenyl)-3H-1,2,4-triazol-3-one (5b, C11H14N4O)

Yield 1.65 g (76%); m.p.: 110–112 °C; IR (KBr): Inline graphic = 3,283, 3,088, 3,015, 2,854, 1,697, 1,647, 1,461 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.49 (s, 3H), 3.83 (s, 2H), 4.12–4.14 (m, 2H), 4.92–5.13 (m, 2H), 5.66–5.83 (m, 1H), 5.88–6.66 (m, 3H, pyrrol-H), 11.52 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 22.17 (CH2), 32.04 (CH3), 40.86 (CH2), 104.95 (CH), 106.51 (Carom), 115.14 (CH2), 121.14, 123.62, 131.36, 143.80 (5 × Carom), 153.38 (C=O) ppm.

2,4-Dihydro-4-(2-propenyl)-5-(pyridin-2-yl)-3H-1,2,4-triazol-3-one (9b, C10H10N4O)

Yield 1.37 g (68%); m.p.: 183–184 °C; IR (KBr): Inline graphic = 3,180, 3,014, 2,953, 2,814, 1,964, 1,640, 1,454 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.50–3.59 (m, 2H), 4.11–4.77 (m, 2H), 5.11–5.16 (m, 1H), 7.02–7.30 (m, 4H, pyridine-H), 11.05 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 39.00 (CH2), 42.29 (CH2), 114.71 (CH), 132.20, 136.00, 142.62, 145.61, 147.47 (6 × Carom), 153.75 (C=O) ppm.

2,4-Dihydro-4-(2-propenyl)-5-[(pyridin-4-yl)methyl]-3H-1,2,4-triazol-3-one (10b, C11H12N4O)

Yield 1.60 g (74%); m.p.: 255–257 °C; IR (KBr): Inline graphic = 3,180, 3,065, 2,790, 2,654, 1,703, 1,639, 1,457 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 4.25 (s, 2H), 4.21–4.27 (m, 2H), 4.93–5.09 (m, 2H), 5.71–5.84 (m, 1H), 7.95–8.88 (m, 4H, pyridine-H), 11.79 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 29.80 (CH2), 39.05 (CH2), 40.81 (CH2), 115.45 (CH), 126.38, 131.16, 139.92, 142.93 (6 × Carom), 154.29 (C=O) ppm.

4-Cyclohexyl-2,4-dihydro-5-[(pyridin-4-yl)methyl]-3H-1,2,4-triazol-3-one (11b, C14H18N4O)

Yield 2.06 g (80%) m.p.: 237–238 °C; IR (KBr): Inline graphic = 3,231, 3,075, 2,916, 1,687, 1,564 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 0.96–2.06 (m, 10H), 3.48–3.61 (m, 1H), 4.00 (s, 2H), 7.27–8.53 (m, 4H, pyridine-H), 11.48 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 24.53 (CH2), 25.14 (2 × CH2), 28.97 (2 × CH2), 30.94 (CH2), 53.97 (CH), 123.92, 144.96, 145.06, 149.74 (6 × Carom), 154.69 (C=O) ppm.

4-(4-Ethoxyphenyl)-2,4-dihydro-5-[(pyridin-4-yl)methyl]-3H-1,2,4-triazol-3-one (12b, C16H16N4O2)

Yield 2.10 g (71%); m.p.: 180–181 °C; IR (KBr): Inline graphic = 3,231, 3,074, 2,917, 1,678, 1,475 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 1.32 (t, J = 6.9 Hz, 3H), 3.82 (s, 2H), 4.05 (q, J = 6.9 Hz, 2H), 6.94–7.07 (m, 4H, phenyl-H), 7.14–8.41 (m, 4H, pyridine-H), 11.76 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 14.49 (CH3), 31.23 (CH2), 63.36 (CH2), 114.86, 124.06, 124.96, 128.82, 144.42, 144.99, 149.22, 154.54 (12 × Carom), 158.42 (C=O) ppm.

2,4-Dihydro-5-(phenylmethyl)-4-(2-propenyl)-3H-1,2,4-triazol-3-one (13b, C12H13N3O)

Yield 1.57 g (73%); m.p.: 105–108 °C; IR (KBr): Inline graphic = 3,143, 3,064, 2,780, 1,702, 1,641, 1,449 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 3.30–3.45 (m, 2H), 4.10 (s, 2H), 4.66–5.05 (m, 2H), 5.40–5.70 (m, 1H), 6.93–7.32 (m, 5H, phenyl-H), 11.64 (s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 31.44 (CH2), 40.05 (CH2), 116.55 (CH2), 126.85 (CH), 128.54, 128.64, 132.48, 135.19, 146.23 (7 × Carom), 154.81 (C=O) ppm.

4,4′-(Methylenedi-4,1-phenylene)bis(5-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one) (15b, C21H22N6O2)

Yield 2.61 g (68%); m.p.: 308–310 °C; IR (KBr): Inline graphic = 3,176, 3,066, 2,955, 1,698, 1,580, 1,417 cm−1; 1H NMR (300 MHz, DMSO-d 6): δ = 1.00 (t, J = 4.6 Hz, 6H), 2.36 (q, J = 7.4 Hz, 4H), 3.32 (s, 2H), 7.05–7.94 (m, 8H, phenyl-H), 11.59 (s, 2NH) ppm; 13C NMR (62.5 MHz, DMSO-d 6): δ = 8.30 (2 × CH3), 17.92 (2 × CH2), 39.05 (CH2), 126.05, 128.32, 139.98 (14 × Carom), 146.54 (2 × C=O) ppm.

UV-Vis spectroscopy

UV-Vis spectra were recorded in water (buffer)-methanol (1:1) solution on a UV-160A Shimadzu Spectrophotometer. Quartz cuvettes (1 cm) were used for measurements.

Liquid chromatography

HPLC was carried out using a liquid chromatograph (Knauer, Berlin, Germany) with a dual pump, a 20-mm3 simple injection valve and a UV–visible detector at 254 nm. The samples were prepared as solutions in methanol.

RP-8 chromatography

A Hypersil MOS2 C8 (5 μm, 150 × 4.6 mm) column was used as the stationary phase. The mobile phase consisted of different volume mixtures of methanol and 20 mM acetate buffer (KCl) as the aqueous phase to give pH 7.4. The methanol concentration ranged from 0.10 to 0.70 at 0.1 (0.05) intervals. The flow rate was 1 cm3 min−1 at room temperature. The retention time of an unretained solute (t 0) was determined by the injection of a small amount of acetone dissolved in water.

RP-18 chromatography

A Hypersil Gold C18 (3 μm, 100 × 3 mm) column was used as the stationary phase. The mobile phase consisted of different volume mixtures of methanol and 20 mM phosphate buffer as the aqueous phase to give pH 7.4. The methanol concentration ranged from 0.30 to 0.75, depending on the structure of compound, at 0.05 (0.1) intervals. The flow rate was 0.5 cm3 min−1 at room temperature. The retention time of an unretained solute (t 0) was determined by the injection of a small amount of acetone dissolved in water.

IAM chromatography

A Rexchrom IAM.PC.DD2 (12 μm, 100 × 4.6 mm, 300 Å) (Regis Technologies) column was used as the stationary phase. The mobile phase consisted of different volume mixtures of acetonitrile and 20 mM phosphate buffer as the aqueous phase to give pH 7.4 (0.02 M KH2PO4, Na2HPO4, and 0.15 M KCl). The acetonitrile concentration ranged from 0 to 0.50, depending on the structure of compound, at 0.05 intervals. The flow rate was 1 cm3 min−1 at room temperature. The retention time of an unretained solute (t 0) was determined by the injection of a small amount of citric acid dissolved in water [36, 37].

Computational methods

The 3D structure of each compound was built up from the fragment library in the PC SPARTAN Pro ver 1.08 molecular modeling program, and it was fully geometry-optimized at the semi-empirical PM3 level [38]. The energy-minimized structure was subjected to conformational analysis implemented in SPARTAN. Conformational analysis was carried out through systemic conformation option. The conformers of the lowest energy were compared. The log P values were calculated using ChemDraw Ultra 10.0 [39].

Statistic analysis

The coefficients in the regression equations were calculated by the multiple regression analysis program Statistica, version 7.1 [40]. Statistical significance of the regression equation was tested by the correlation coefficient (r), the standard error of estimate (s) and the variance ratio (F) at specified degrees of freedom (df), n number of compounds.

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

References

  • 1.Aher NG, Pore VS, Mishra NN, Kumar A, Shukla PK, Sharma A, Bhat MK. Bioorg Med Chem Lett. 2009;19:759. doi: 10.1016/j.bmcl.2008.12.026. [DOI] [PubMed] [Google Scholar]
  • 2.Bhat AR, Bhat GV, Shenoy GG. J Pharm Pharmacol. 2001;53:267. doi: 10.1211/0022357011775307. [DOI] [PubMed] [Google Scholar]
  • 3.Trzaskos JM, Bowen WD, Shafiee A, Fischer RT, Gaylor JL. J Biol Chem. 1984;259:13402. [PubMed] [Google Scholar]
  • 4.Demirbas N, Ugurlouglu SA, Demirbas A. Biorg Med Chem. 2002;10:3717. doi: 10.1016/S0968-0896(02)00420-0. [DOI] [PubMed] [Google Scholar]
  • 5.Yüksen H, Demirbaş A, Ikizler A, Johansson CB, Celik C, Ikizler AA. Arzneim Forsch. 1997;47:405. [PubMed] [Google Scholar]
  • 6.Hui XP, Zhang L, Zhang ZY, Wang Q, Wang F. J Chin Chem Soc. 2000;47:535. [Google Scholar]
  • 7.Trsukuda T, Shiratoi Y, Watanabe M, Ohtsuka H, Hattori K, Shirai M, Shimma N. Bioorg Med Chem Lett. 1998;8:1819. doi: 10.1016/S0960-894X(98)00316-3. [DOI] [PubMed] [Google Scholar]
  • 8.Witoaski JT, Robins RK, Sidwel RW, Simon LN. J Med Chem. 1972;15:1150. doi: 10.1021/jm00281a014. [DOI] [PubMed] [Google Scholar]
  • 9.Kritsanida M, Mouroutsou A, Marakos P, Pouli N, Papakonstantinou-Garoufalias S, Pannecougue C, Witvouw M, De Clerq E (2002) Il Farmaco 57:253 [DOI] [PubMed]
  • 10.Walczak K, Gondela A, Suwiński J. Eur J Med Chem. 2004;39:849. doi: 10.1016/j.ejmech.2004.06.014. [DOI] [PubMed] [Google Scholar]
  • 11.Amir M, Shikha K. Eur J Med Chem. 2004;39:535. doi: 10.1016/j.ejmech.2004.02.008. [DOI] [PubMed] [Google Scholar]
  • 12.Shiradkar MR, Ahivaprasadh N. Asian J Chem. 2006;18:319. [Google Scholar]
  • 13.Pitucha M, Chodkowska A, Maciejewski M, Jagiełło-Wójtowicz E, Pachuta-Stec A. Monatsh Chem. 2010;141:199. doi: 10.1007/s00706-009-0242-3. [DOI] [Google Scholar]
  • 14.Valko K, Sleger P. J Chromatogr A. 1993;669:346. [Google Scholar]
  • 15.Valko K. J Chromatogr A. 2004;1037:299. doi: 10.1016/j.chroma.2003.10.084. [DOI] [PubMed] [Google Scholar]
  • 16.Kaliszan R, Nasal A, Markuszewski MJ. Anal Bioanal Chem. 2003;377:803. doi: 10.1007/s00216-003-2070-3. [DOI] [PubMed] [Google Scholar]
  • 17.Matysiak J, Niewiadomy A, Mącik-Niewiadomy G. Eur J Pharm Sci. 2000;10:119. doi: 10.1016/S0928-0987(99)00096-2. [DOI] [PubMed] [Google Scholar]
  • 18.Ong S, Liu H, Qui X, Bhat G, Pidgeon C. Anal Chem. 1995;67:755. doi: 10.1021/ac00100a011. [DOI] [PubMed] [Google Scholar]
  • 19.Nasal A, Sznitowska M, Bucinski A, Kaliszan R. J Chromatogr A. 1995;692:83. doi: 10.1016/0021-9673(94)00689-7. [DOI] [Google Scholar]
  • 20.Pidgeon C, Venkataram UV. Anal Biochem. 1989;176:36. doi: 10.1016/0003-2697(89)90269-8. [DOI] [PubMed] [Google Scholar]
  • 21.Soczewiński E, Wachtmeister CA. J Chromatogr A. 1962;7:311. doi: 10.1016/S0021-9673(01)86422-0. [DOI] [Google Scholar]
  • 22.Snyder LR, Dolan JW, Gant JR. J Chromatogr A. 1979;165:3. doi: 10.1016/S0021-9673(00)85726-X. [DOI] [Google Scholar]
  • 23.Hollósy F, Lorand T, Örfi L, Erös D, Kéri G, Idei M. J Chromatogr B. 2002;768:361. doi: 10.1016/S1570-0232(02)00004-1. [DOI] [PubMed] [Google Scholar]
  • 24.Kaliszan R. Quantitative structure—chromatographic retention relationship. New York: Jon Wiley & Sons; 1987. [Google Scholar]
  • 25.Biagi GL, Barbaro AM, Sapone A, Recanatini (1994) J Chromatogr A 669:246
  • 26.Todeschini R, Consonni V. Molecular descriptors for chemoinformatics; methods and principles in medicinal chemistry. Weinheim: Wiley-VCH; 2009. [Google Scholar]
  • 27.Ghose AK, Crippen GM. J Chem Inf Comput Sci. 1987;27:21. doi: 10.1021/ci00053a005. [DOI] [PubMed] [Google Scholar]
  • 28.Ward RS, Davies J, Hodges G, Roberts DW. J Chromatogr A. 2003;1007:67. doi: 10.1016/S0021-9673(03)00947-6. [DOI] [PubMed] [Google Scholar]
  • 29.Abraham MH, Chadha HS, Leitao RAE, Mitchell RC, Lambert WJ, Kaliszan R, Nasal A, Haber P. J Chromatogr A. 1997;766:35. doi: 10.1016/S0021-9673(96)00977-6. [DOI] [Google Scholar]
  • 30.Kaliszan R. Trends Anal Chem. 1999;18:400. doi: 10.1016/S0165-9936(99)00120-X. [DOI] [Google Scholar]
  • 31.Pitucha M, Polak B, Świeboda R, Kosikowska U, Malm A (2009) Z Naturforsch 64b:570
  • 32.Pitucha M, Olender A, Wujec M, Borowski P, Mardarowicz M. J Chin Soc. 2010;57:260. [Google Scholar]
  • 33.Pitucha M, Borowski P, Karczmarzyk Z, Fruziński A. J Mol Struct. 2009;919:170. doi: 10.1016/j.molstruc.2008.09.002. [DOI] [Google Scholar]
  • 34.Ismail I, Imam I, El-Azeem AH, Abd A. Chem Chem Eng. 1995;39:19. [Google Scholar]
  • 35.Pitucha M, Karczmarzyk Z, Kosikowska U, Malm A (2011) Z Naturforsch 66b:505
  • 36.Ward RS, Davies J, Hodges G, Roberts DW (2003) J Chromatogr A 1007:67 [DOI] [PubMed]
  • 37.Taillardat-Bertschinger A, Galland A, Carrupt PA, Testa B. J Chromatogr A. 2002;953:39. doi: 10.1016/S0021-9673(02)00119-X. [DOI] [PubMed] [Google Scholar]
  • 38.PC Spartan Pro (1999) Wavefunction Inc, California
  • 39.ChemOffice (2006) CambridgeSoft Corporation, Cambridge
  • 40.Statistica 7.1 (2005) StatSoft Inc, Tulsa

Articles from Monatshefte Fur Chemie are provided here courtesy of Springer

RESOURCES